InsidersTradesSigma
Explore the complete record of transactions filed by Freeman Jonathan E, Director. Director active across 1 company, notably Phio Pharmaceuticals Corp.. In total, 1 reports have been logged. Activity tracked since 15 February 2022. The latest transaction was disclosed on 15 February 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration
Jonathan E. Freeman serves as a Director at Phio Pharmaceuticals Corp. In this role, he contributes to the governance of the company by participating in strategic decisions and ensuring that shareholder interests are protected. Jonathan plays a vital role in guiding the direction of Phio.